Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American heart association

Circulation

Volumn 119, Issue 17, 2009, Pages 2408-2416

  Hlatky, Mark A ^a   Greenland, Philip ^a   Arnett, Donna K ^a   Ballantyne, Christie M ^a   Criqui, Michael H ^a   Elkind, Mitchell S V ^a   Go, Alan S ^a   Harrell, Frank E ^a   Howard, Barbara V ^a   Howard, Virginia J ^a   Hsue, Priscilla Y ^a   Kramer, Christopher M ^a   McConnell, Joseph P ^a   Normand, Sharon Lise T ^a   O'Donnell, Christopher J ^a   Smith, Sidney C ^a   Wilson, Peter W F ^a  

^a NONE

Author keywords

AHA Scientific Statements; Evaluation studies; Models, statistical; Risk assessment

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HUMAN; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; VALIDATION STUDY; ARTICLE; CARDIOVASCULAR DISEASE; EVALUATION; MEDICAL SOCIETY; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED STATES;

AMERICAN HEART ASSOCIATION; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; EVALUATION STUDIES AS TOPIC; HUMANS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 66349111734     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.192278     Document Type: Review

References (18)

1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
2. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290: 932-940.
3. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS, Harrington RA, Abrams J, Anderson JL, Bates ER, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ; American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography);Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron-Beam Computed Tomoraphy). Circulation. 2007;115:402-426.
4. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vanden-broucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies [published correction appears in Ann Intern Med. 2008;148:168]. Ann Intern Med. 2007;147:573-577.
5. Harrell FE Jr. Regression Modeling Strategies, With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
6. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
7. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285-1293.
8. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159:882-890.
9. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935.
10. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16:965-980.
11. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
12. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
13. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298:776-785.
14. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1980;302:1109-1117.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486-2497.
16. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM; the Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360:1531-1539.
17. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350: 647-654.
18. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006;48: 1319-1325.